Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 2
1988 1
1989 6
1990 7
1991 6
1992 4
1993 7
1994 4
1995 8
1996 6
1997 9
1998 9
1999 2
2000 8
2001 5
2002 6
2003 10
2004 8
2005 10
2006 1
2007 5
2008 5
2009 5
2010 14
2011 8
2012 7
2013 12
2014 5
2015 6
2016 5
2017 9
2018 6
2019 7
2020 3
2021 8
2022 8
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
The role of CD4 T cells in rejection of solid tumors.
Poncette L, Bluhm J, Blankenstein T. Poncette L, et al. Among authors: blankenstein t. Curr Opin Immunol. 2022 Feb;74:18-24. doi: 10.1016/j.coi.2021.09.005. Epub 2021 Oct 4. Curr Opin Immunol. 2022. PMID: 34619457 Free PMC article. Review.
IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis.
Garnier L, Pick R, Montorfani J, Sun M, Brighouse D, Liaudet N, Kammertoens T, Blankenstein T, Page N, Bernier-Latamani J, Tran NL, Petrova TV, Merkler D, Scheiermann C, Hugues S. Garnier L, et al. Among authors: blankenstein t. Sci Adv. 2022 Jun 10;8(23):eabl5162. doi: 10.1126/sciadv.abl5162. Epub 2022 Jun 8. Sci Adv. 2022. PMID: 35675399 Free PMC article.
Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry.
Ben Hamza A, Welters C, Stadler S, Brüggemann M, Dietze K, Brauns O, Brümmendorf TH, Winkler T, Bullinger L, Blankenstein T, Rosenberger L, Leisegang M, Kammertöns T, Herr W, Moosmann A, Strobel J, Hackstein H, Dornmair K, Beier F, Hansmann L. Ben Hamza A, et al. Among authors: blankenstein t. Blood. 2024 Apr 4;143(14):1365-1378. doi: 10.1182/blood.2023023142. Blood. 2024. PMID: 38277625
The determinants of tumour immunogenicity.
Blankenstein T, Coulie PG, Gilboa E, Jaffee EM. Blankenstein T, et al. Nat Rev Cancer. 2012 Mar 1;12(4):307-13. doi: 10.1038/nrc3246. Nat Rev Cancer. 2012. PMID: 22378190 Free PMC article. Review.
[Often not requiring therapy].
Jückstock J, Blankenstein T, Weiß F, Mahner S. Jückstock J, et al. Among authors: blankenstein t. MMW Fortschr Med. 2020 Jan;162(1):60-61. doi: 10.1007/s15006-020-0063-1. MMW Fortschr Med. 2020. PMID: 31960301 Review. German. No abstract available.
[Vaginal bleeding - red flags for the general practitioner].
Wagner F, Blankenstein T. Wagner F, et al. Among authors: blankenstein t. MMW Fortschr Med. 2022 Apr;164(8):56-57. doi: 10.1007/s15006-022-0923-y. MMW Fortschr Med. 2022. PMID: 35449282 Review. German. No abstract available.
CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.
Herrmann A, Lahtz C, Nagao T, Song JY, Chan WC, Lee H, Yue C, Look T, Mülfarth R, Li W, Jenkins K, Williams J, Budde LE, Forman S, Kwak L, Blankenstein T, Yu H. Herrmann A, et al. Among authors: blankenstein t. Cancer Res. 2017 Sep 15;77(18):5118-5128. doi: 10.1158/0008-5472.CAN-16-0342. Epub 2017 Jul 17. Cancer Res. 2017. PMID: 28716895 Free PMC article.
Immunotherapy: target the stroma to hit the tumor.
Kammertoens T, Schüler T, Blankenstein T. Kammertoens T, et al. Among authors: blankenstein t. Trends Mol Med. 2005 May;11(5):225-31. doi: 10.1016/j.molmed.2005.03.002. Trends Mol Med. 2005. PMID: 15882610 Review.
230 results